Vivelle-Dot vs. Climara

See how Vivelle-Dot and Climara compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Vivelle-Dot and Climara both deliver estradiol through a skin patch, but Vivelle-Dot is changed twice a week while Climara only needs changing once a week.

  • Vivelle-Dot's patches are smaller, from 2.5 to 10 cm², while Climara's range from 6.5 to 25 cm², so size and visibility on skin differ noticeably.

  • Climara offers six dose strengths, including a 0.06 mg option Vivelle-Dot doesn't have, giving slightly more room to fine-tune the dose.

Vivelle-Dot vs. Climara Drug Summary

Vivelle-Dot

Vivelle-Dot is an estradiol patch, a form of hormone replacement therapy, used to treat moderate to severe hot flashes and vaginal dryness from menopause, low estrogen from ovarian failure, and to help prevent osteoporosis after menopause. It's applied to the lower abdomen or buttock and changed twice a week.

Climara

Climara is also an estradiol patch used as hormone replacement therapy for the same core reasons: moderate to severe hot flashes, vaginal dryness from menopause, low estrogen from ovarian failure, and osteoporosis prevention. One patch is worn on the lower abdomen and changed just once a week.

Vivelle-Dot vs. Climara Side Effects

Vivelle-Dot

Most common
Upper respiratory tract infection (≥10%)
Headache (≥10%)
Breast pain (≥10%)
Back pain (≥10%)

Climara

Most common
Upper respiratory tract infection (≥10%)
Headache (≥10%)
Breast pain (≥10%)
Abdominal pain (≥10%)

Vivelle-Dot vs. Climara Dosage

Vivelle-Dot

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day patch At the start
Maximum dose 0.1 mg/day patch If needed
Dose changes 4 increases As tolerated

Climara

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day patch At the start
Maximum dose 0.1 mg/day patch If needed
Dose changes 5 increases As tolerated

Vivelle-Dot vs. Climara Indications

Vivelle-Dot

Vivelle-Dot is FDA-approved for moderate to severe hot flashes and vaginal or vulvar dryness tied to menopause, for low estrogen from ovarian failure or hypogonadism, and for preventing bone loss after menopause. Some clinicians also prescribe it off-label as part of feminizing hormone therapy for transgender women.

  • Moderate to severe hot flashes (vasomotor symptoms) of menopause

  • Vaginal and vulvar dryness or atrophy from menopause

  • Low estrogen (hypoestrogenism) from ovarian failure, hypogonadism, or castration

  • Prevention of postmenopausal osteoporosis

  • Off-label: feminizing hormone therapy for transgender women

Climara

Climara carries the same core approvals: moderate to severe menopausal hot flashes, vaginal and vulvar atrophy, low estrogen from ovarian failure or hypogonadism, and prevention of postmenopausal osteoporosis. It's also used off-label as part of feminizing hormone therapy for transgender women.

  • Moderate to severe hot flashes (vasomotor symptoms) of menopause

  • Vaginal and vulvar dryness or atrophy from menopause

  • Low estrogen (hypoestrogenism) from ovarian failure, hypogonadism, or castration

  • Prevention of postmenopausal osteoporosis

  • Off-label: feminizing hormone therapy for transgender women

Vivelle-Dot vs. Climara Pros and Cons

Vivelle-Dot

Vivelle-Dot delivers the same estradiol hormone as other patches, so its cardiovascular, cancer, and dementia risks mirror Climara's. The real differences patients notice are patch size, how often it's changed, and the number of dose strengths available.

Pros

  • Smaller patch (2.5 to 10 cm²) that's less visible under clothing than Climara's larger sizes.

  • Twice-weekly changes may give steadier estrogen levels between applications than once-a-week dosing.

  • FDA-approved since 1996, with decades of real-world use in menopause care.

Cons

  • Requires a new patch twice a week instead of once, meaning more frequent site changes.

  • Comes in five dose strengths, one fewer than Climara's six, slightly limiting fine-tuning.

  • No manufacturer copay card is currently offered for brand-name Vivelle-Dot.

Climara

Climara delivers estradiol through the skin just like Vivelle-Dot, so it carries the same core estrogen-related risks and benefits. What sets it apart for patients is a larger patch, weekly rather than twice-weekly changes, and one extra dose strength.

Pros

  • Only needs changing once a week instead of twice, meaning fewer patch changes overall.

  • Offers six dose strengths, including a 0.06 mg option, for finer titration than Vivelle-Dot's five.

  • Longer FDA track record, approved since 1975, over two decades before Vivelle-Dot.

Cons

  • Larger patch (6.5 to 25 cm²) may be more visible under fitted clothing than Vivelle-Dot's smaller sizes.

  • Each patch holds more total hormone in reserve (up to 7.6 mg) than Vivelle-Dot's highest strength (up to 1.56 mg).

  • Once-a-week dosing means waiting longer to switch strengths if a dose isn't working well.

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.